H
Hanna Hlawaty
Researcher at Sorbonne
Publications - 31
Citations - 1034
Hanna Hlawaty is an academic researcher from Sorbonne. The author has contributed to research in topics: Chemokine & Angiogenesis. The author has an hindex of 18, co-authored 30 publications receiving 881 citations. Previous affiliations of Hanna Hlawaty include Paris Diderot University & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans
Nadine Suffee,Hanna Hlawaty,Anne Meddahi-Pellé,Loïc Maillard,Liliane Louedec,Oualid Haddad,Loïc Martin,Christelle Laguillier,Benjamin Richard,Olivier Oudar,Didier Letourneur,Nathalie Charnaux,Angela Sutton +12 more
TL;DR: It is demonstrated that chemokine oligomerization and binding to GAGs are essential in RANTES/CCL5-induced angiogenic effects and new therapeutic strategies can be proposed for neo-angiogenesis after vascular injury.
Journal ArticleDOI
Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.
Maylis Dagouassat,Nadine Suffee,Hanna Hlawaty,Oualid Haddad,Faten Charni,Christelle Laguillier,Roger Vassy,Loïc Martin,Pierre-Olivier Schischmanoff,Liliane Gattegno,Olivier Oudar,Angela Sutton,Nathalie Charnaux +12 more
TL;DR: The data show that human liver myofibroblasts act on hepatoma cells in a paracrine manner to increase their invasiveness and suggest that my ofibroblast‐derived MCP‐1/CCL2 could be involved in the pathogenesis of hepatocellular carcinoma.
Journal ArticleDOI
Angiogenic properties of the chemokine RANTES/CCL5.
TL;DR: The present review focuses on the angiogenic activity of the chemokines RANTES (regulated upon activation, normal T-cell expressed and secreted)/CCL5 (CC chemokine ligand 5), which is released by many cell types such as platelets or smooth muscle cells.
Journal ArticleDOI
Fucoidan/VEGF-based surface modification of decellularized pulmonary heart valve improves the antithrombotic and re-endothelialization potential of bioprostheses.
Nicolas Marinval,M. Morenc,Marie-Noëlle Labour,A. Samotus,Aldona Mzyk,Véronique Ollivier,Murielle Maire,K. Jesse,K. Bassand,A. Niemiec-Cyganek,Oualid Haddad,Marie-Paule Jacob,Frédéric Chaubet,Nathalie Charnaux,P. Wilczek,Hanna Hlawaty +15 more
TL;DR: The fucoidan/VEGF PEM coated valve scaffold is a promising surface modification to obtain valve bioprostheses for clinical applications with increased antithrombotic and re-endothelialization potential.
Journal ArticleDOI
Fucoidan in a 3D scaffold interacts with vascular endothelial growth factor and promotes neovascularization in mice
Agung Purnama,Agung Purnama,Rachida Aid-Launais,Oualid Haddad,Muriel Maire,Diego Mantovani,Didier Letourneur,Didier Letourneur,Hanna Hlawaty,Hanna Hlawaty,Catherine Le Visage,Catherine Le Visage +11 more
TL;DR: It is shown that hydrogels functionalized with fucoidan can direct the formation of mature vasculature through a local release of VEGF165 and can be a useful tool in ischemic tissues to guide therapeutic angiogenesis.